A mouse model for valproate teratogenicity: Parental effects, homeotic transformations, and altered HOX expression

Human Molecular Genetics

Volumn 9, Issue 2, 2000, Pages 227-236

  Faiella, Antonio ^a   Wernig, Marius ^b   Consalez, G Giacomo ^a   Hostick, Ute ^b   Hofmann, Clementine ^b   Hustert, Elisabeth ^b   Boncinelli, Edoardo ^a   Balling, Rudi ^b   Nadeau, Joseph H ^c,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; RETINOIC ACID; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL GENETICS; EMBRYO; EMBRYONAL CARCINOMA; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HOMEOBOX; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TERATOGENICITY;

ANIMALIA; MAMMALIA;

EID: 0033968253     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.2.227     Document Type: Article

References (76)

1. Guay, D.R. (1995) The emerging role of valproate in bipolar disorder and other psychiatric disorders. Pharmacotherapy, 15, 631-647.
2. Feely, M. (1999) Fortnightly review: drug treatment of epilepsy. Br. Med. J., 318, 106-109.
3. Tohen, M. and Grundy, S. (1999) Management of acute mania. J. Clin. Psychiat., 60(Suppl. 5), 31-34.
4. Finnell, R.H. (1991) Genetic differences in susceptibility to anticonvulsant drug-induced developmental defects. Pharmacol. Toxicol., 69, 223-227.
5. Robert, E. (1991) Risques teratogenes de l'epilepsie et des antiepileptiques. Pediatrie, 46, 579-583.
6. Lindhout, D. and Omtzigt, J.G. (1992) Pregnancy and the risk of teratogenicity. Epilepsia, 33(Suppl. 4), S41-S48.
7. Robert, E. and Guibaud, P. (1982) Maternal valproic acid and congenital neural tube defects. Lancet, ii, 937.
8. Robert, E. and Rosa, F. (1983) Valproate and birth defects. Lancet, ii, 1142.
9. Lindhout, D. and Schmidt, D. (1986) In-utero exposure to valproate and neural tube defects. Lancet, i, 1392-1393.
10. Lammer, E.J., Sever, L.E. and Oakley, G.P. (1987) Teratogen update: valproic acid. Teratology, 35, 465-47.1.
11. Clayton-Smith, J. and Donnai, D. (1995) Fetal valproate syndrome. J. Med. Genet., 32, 724-727.
12. Jones, K.L., Lacro, R.V., Johnson, K.A. and Adams, J. (1989) Patterns of malformations in the children of women treated with carbamazepine during pregnancy. N. Engl. J. Med., 320, 1661-1666.
13. Koch, S., Losche, G., Jager-Roman, E., Jakob, S., Rating, D., Diechl, A. and Helge, H. (1992) Major and minor birth malformations and antiepileptic drugs. Neurology, 42(Suppl. 5), 83-88.
14. Ehlers, K., Sturje, H., Merker, H.J. and Nau, H. (1992) Spina bifida aperta induced by valproic acid and by all-trans-retinoic acid in the mouse: distinct differences in morphology and periods of sensitivity. Teratology, 46, 117-130.
15. Nau, H., Hauck, R.S. and Ehlers, K. (1991) Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Pharmacol. Toxicol., 69, 310-321.
16. Ehlers, K., Stürje, H., Merker, H.-J. and Nau, H. (1992) Valproic acid-induced spina bifida: a mouse model. Teratology, 45, 145-154.
17. Narotsky, M.G., Francis, E.Z. and Kaviock, R.J. (1994) Developmental toxicity and structure-activity relationships of aliphatic acids, including dose-response assessment of valproic acid in mice and rats. Fundam. Appl. Toxicol., 22, 251-265.
18. Kao, J., Brown, N., Schmid, B., Goulding, E. and Fabro, S. (1981) Teratogenicity of valproic acid: in vivo and in vitro investigations. Teratogen. Carcinogen. Mutagen., 1, 367-382.
19. Naruse, I., Collins, M.D. and Scott, W.J. (1988) Strain differences in the teratogenicity induced by sodium valproate in cultured mouse embryos. Teratology, 38, 87-96.
20. Finnell, R.H., Bennett, G.D., Karras, S.B. and Mohl, V.K. (1988) Common hierarchies of susceptibility to the induction of neural tube defects in mouse embryos by valproic acid and its 4-propyl-4-pentenoic acid metabolite. Teratology, 38, 313-320.
21. Dansky, L.V., Rosenblatt, D.S. and Andermann, E. (1992) Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology, 42, 32-42.
22. Bui, L.M., Taubeneck, M.W., Commiso, J.F., Uriu-Hare, J.Y., Farber, W.D. and Keen, C.L. (1998) Altered zinc metabolism contributes to the developmental toxicity of 2-ethylhexanoic acid, 2-ethylhexanol and valproic acid. Toxicology, 126, 9-21.
23. Wegner, C., Drews, E. and Nau, H. (1990) Zinc concentrations in mouse embryo and maternal plasma. Effect of valproic acid and non-teratogenic metabolite. Biol. Trace Elem. Res., 25, 211-217.
24. Clarice, D.O. and Brown, N.A. (1987) Valproic acid teratogenesis and embryonic lipid metabolism. Arch. Toxicol., 11(suppl.), 143-147.
25. Nau, H. (1986) Species differences in pharmacokinetics and drug teratogenesis. Environ. Health Perspect., 70, 113-129.
26. Bruckner, A., Lee, Y.J., O'Shea, K.S. and Henneberry, R.C. (1983) Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in culture. Teratology, 27,29-42.
27. Kessel, M. and Gruss, P. (1991) Homeotic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid. Cell, 67, 89-104.
28. Kessel, M. (1992) Respecification of vertebral identities by retinoic acid. Development, 115, 487-501.
29. Mouellic, H., Lallemand, Y. and Brulet, P. (1992) Homeosis in the mouse induced by a null mutation in the Hox-3.1 gene. Cell, 69, 251-254.
30. Fromental-Ramain, C., Warot, X., Lakkaraju, S., Favier, B., Haack, H., Birling, C., Dietrich, A., Dollé, P. and Chambon, P. (1996) Specific and redundant functions of the paralogous Hoxa-9 and Hoxd-9 genes in the forelimb and axial skeleton patterning. Development, 122, 461-472.
31. Koran, G.S., Ramirez-Solis, R., Featherstone, M.S., Wolgemuth, D.J., Bradley, A. and Behringer, R.R. (1995) Compound mutants for the paralogous hoxa-4, hoxb-4, and hoxd-4 genes show more complete homeotic transformations and a dose-dependent increase in the number of vertebrae transformed. Genes Dev., 9, 1667-1777.
32. Jegalian, B.G. and DeRobertis, E.M. (1992) Homeotic transformations in the mouse induced by over-expression of a human Hox3.3 transgene. Cell, 71, 901-910.
33. Balling, R., Mutter, G., Gruss, P. and Kessel, M. (1989) Craniofacial abnormalities induced by ectopic expression of the homeobox gene Hox-1.1 in transgenic mice. Cell, 58, 337-347.
34. Pollack, R.A., Sreenath, T., Ngo, L. and Bieberich, C.J. (1995) Gain of function mutations for paralogous Hox genes: implications for the evolution of Hox gene function. Proc. Natl Acad. Sci. USA, 92, 4492-44496.
35. Lohnes, D., Kastner, P., Dierich, A., Mark, M., LeMeur, M. and Chambon, P. (1993) Function of retinoic acid receptor gamma in the mouse. Cell, 73, 643-658.
36. Lohnes, D., Mark, M., Mendelsohn, C., Dolle, P., Dierich, A., Gorry, P., Gansmuller, A. and Chambon, P. (1994) Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. Development, 120, 2723-2748.
37. Akasaka, T., Kanno, M., Balling, R., Mieza, M.A., Taniguchi, M. and Koseki, H. (1996) A role for mel-18, a Polycomb group-related vertebrate gene, during the anteroposterior specification of the axial skeleton, Development, 122, 1513-1522.
38. Core, N., Bel, S., Gaunt, S.J., Aurrand-Lions, M., Pearce, J., Fisher, A. and Djabali, M. (1997) Altered cellular proliferation and mesoderm patterning in Polycomb-M33-deficient mice. Development, 124, 721-729.
39. Van der Lugt, N.M.T., Domen, J., Linders, K., van Roon, M., Robanus-Maandag, E., te Riele, H., van der Valk, M., Deschamps, J., Sofroniew, M., van Lohuizen, M. et al. (1994) Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev., 8, 757-769.
40. Schumacher, A., Faust, C. and Magnuson, T. (1996) Positional cloning of a global regulator of anterior-posterior patterning in mice. Nature, 383, 250-253.
41. Davis, A.P. and Capecchi, M.R. (1996) A mutational analysis of the 5′ HoxD genes: dissection of genetic interactions during limb development in the mouse. Development, 122, 1175-1185.
42. Dolle, P., Izpisua-Belmonte, J.C., Tickle, C. and Duboule, D. (1993) Hox genes and the morphogenesis of the vertebrate limb. Prog. Clin. Biol. Res., 383A, 11-20.
43. Mavilio, F. (1993) Regulation of vertebrate homeobox-containing genes by morphogens. Eur. J. Biochem., 212, 273-288.
44. Morris-Kay, G.M. and Ward, S.J. (1999) Retinoids and mammalian development. Int. Rev. Cytol., 188, 73-131.
45. Andrews, P.W. (1984) Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol., 103, 285-293.
46. Thompson, S., Stern, P.L., Webb, M., Walsh, F.S., Engstrom, W., Evans, E.P., Shi, W.-K., Hopkins, B. and Graham, C.F. (1984) Cloned human teratoma cells differentiate into neuron-like cells and other cell types in retinoic acid. J. Cell Sci., 72, 37-64.
47. Simeone, A., Acampora, D., Arcioni, L., Andrews, P.W., Boncinelli, E. and Mavilio, F. (1990) Sequential activation of HOX2 homeobox genes by retinoic acid in human embryonal carcinoma cells. Nature. 346, 763-766.
48. Simeone, A., Acampora, D., Negro, V., Faiella, A., D'Esposito, M., Stomaiuolo, A., Mavilo, F. and Boncinelli, E. (1991) Differential regulation by retinoic acid of the homeobox genes of the four HOX loci in human embryonal carcinoma cells. Mech. Dev., 33, 215-227.
49. Faiella, A., Zappavigna, V., Mavilio, F. and Boncinelli, E. (1994) Inhibition of retinoic acid-induced activation of 3′ human HOXB genes by antisense oligonucleolides affects sequential activation of genes located upstream in the four HOX clusters. Proc. Natl Acad. Sci. USA, 91, 5335-5339.
50. Carpenter, E.M., Goddard, J.M., Davis, A.P., Nguyen, T.P. and Capecchi, M.R. (1997) Targeted disruption of Hoxd10 affects mouse hindbrain development. Development, 124, 4505-4514.
51. Solomon, D.A., Keitner, G.I., Miller, I.W., Shea, M.T. and Keller, M.B. (1995) Course of illness and maintenance treatments for patients with bipolar disorder. J. Clin. Psychiatr., 56, 5-13.
52. Retzow, A. and Emrich, H.M. (1998) Therapy for bipolar affective illnesses with valproate. A review of the literature. Psychiatr. Prax., 25, 163-171.
53. Vorhees, C.V., Acuff, K.D., Weisenburger, W.P. and Minck, D.R. (1990) Teratogenicity of carbamazepine in rats. Teratology, 41, 311-317.
54. Abdulrazzaq, Y.M., Bastaki, S. M. and Padmanabhan, R. (1997) Teratogenic effects of vigabatrin in TO mouse fetuses. Teratology, 55, 165-176.
55. Yasuda, M. and Maeda, H. (1972) Teratogenic effects of 4-chloro-2-methylphenoxyacetic acid ethylester (MCPEE) in rats. Toxicol. Appl. Pharmacol., 23, 326-333.
56. Marathe, M.R. and Thomas, G.P. (1986) Embryotoxicity and teratogenicity of lithium carbonate in Wistar rats. Toxicol. Lett., 34, 115-120.
57. Hansen, G.K., Diak, S.L., Terry, K.K. and Grafton, T.F. (1996) In vitro embryotoxicity of carbamazepine and carbamazepine-10, 11-epoxide. Teratology, 54, 45-51.
58. Piersma, A.H., Verhoef, A., Opperhuizen, A., Klaassen, R., van Eijkeren, J. and Oiling, M. (1998) Embryotoxicity of carbamazepine in rat poslimplantation embryo culture after in vitro exposure via three different routes. Reprod. Toxicol., 12, 161-168.
59. Powell-Jackson, P.R., Tredger, J.M. and Williams, R. (1984) Hepatotoxicity to sodium valproate: a review. Gut, 25, 673-681.
60. Cotariu, D. and Zaidman, J.L. (1988) Valproic acid and the liver. Clin. Chem., 34, 890-897.
61. Sobaniec-Lowtowska, M.E. (1997) Effects of long-term administration of the antiepileptic drug sodium valproate upon the ultrastructure of hepatocytes in rats. Exp. Toxicol. Pathol., 49, 225-232.
62. -/- embryos. Development, 125, 533-544.
63. Ponchaut, S., van Hoof, F. and Veitch, K. (1992) In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions. Biochem. Pharmacol., 43, 2435-2442.
64. Krahenbuhl, S., Mang, G., Kupferschmidt, H., Meier, P.J. and Krause, M. (1995) Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate hepatotoxicity. Gut. 37, 140-143.
65. Coakley, M.E., Rawlings, S.J. and Brown, N.A. (1986) Short-term carboxylic acids, a new class of teratogens: studies of potential biochemical mechanisms. Environ. Health Perspect., 70, 105-111.
66. Trotz, M., Wegner, C. and Nau, H. (1987) Valproic acid-induced neural tube defects: reduction by folinic acid in the mouse. Life Sci., 41, 103-110.
67. Hansen, D.K. and Grafton, T.F. (1991) Lack of attenuation of valproic acid-induced effects of folinic acid in rat embryos in vitro. Teratology, 43, 575-582.
68. Hansen, D.K., Grafton, T.F., Dial, S.L., Gehring, T.A. and Siitonen, P.H. (1995) Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo. Teratology, 52, 277-285.
69. Michal, G. (1999) Biochemical Pathways. John Wiley and Sons, New York, NY.
70. Chen, G., Yuan, P.X., Jiang, Y.M., Huang, L.D. and Manji, H.K. (1999) Valproate robustly enhances AP-1 mediated gene expression. Brain Res. Mol. Brain Res., 64, 52-58.
71. Chen, B., Wang, J.F., Hill, B.C. and Young, L.T. (1999) Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-FOS. Brain Res. Mol. Brain Res., 70, 45-53.
72. Klein, P.S. and Melton, D.A. (1996) A molecular mechanism for the effect of lithium on development. Proc. Natl Acad. Sci. USA, 93, 8455-8459.
73. Nau, H. (1985) Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse. Toxicol. Appl. Pharmacol., 80, 243-250.
74. Washburn, S.L. and Buettner-Janusch, J. (1952) The definition of thoracic and lumbar vertebrae. Am. J. Phys. Anthrop., 10, 251-252.
75. Struthers, J. (1875) On variations of the vertebrae and ribs in man. J. Anat. Phys., IX, 17-96.
76. Pollack, R.A., Gilbert, J. and Bieberich, C.J. (1992) Altering the boundaries of Hox3.1 expression: evidence for antipodal gene regulation. Cell, 71, 911-923.